Genetic breakthroughs open up the revolution in cancer treatment

Scientists in the UK have completed the complete genetic map of the two most common lung and skin cancers, which are considered the basis for a revolution in treating this incurable disease.

The work is the result of a study published Dec. 15 by an international team of experts led by Professor Mike Stratton at the Cancer Genetics Project, the Institute of the Wellcome Trust Sanger (UK).

Professor Stratton stated: 'These findings may change the way we look at cancer. The mutant list shows how cancer develops, and shows how to prevent it. These gene mutations will tell which growth process is stopped in cancer cells. '

An unprecedented genetic map, with a list of all DNA mutations found in tumors of two cancer patients with tumors in the lung and malignant melanoma on the skin, is considered one of the steps. The most important advance in cancer research over the past decade.

Cancer is a genetic disease, environmental factors such as smoking, radiation or alcohol cause DNA destruction and lead to uncontrolled growth of cells.

The study also found that an average smoker will have a daily mutation. Tumors in lung cancer patients aged 55 in the study had 22,910 different genetic changes, largely due to carcinogenic carcinogenic substances from tobacco.

Scientists predict that by 2020, all cancer patients will be analyzed for tumors to find the pathogen that is causing the disease and this information will be used to select effective treatments. Best.

In the coming time, experts in many countries will focus on tumors on 500 patients with different types of cancer to compare with healthy gene codes to find out which DNA defect is the cause of cancer. .

Accordingly, the UK will continue to map breast cancer genes, Japan, India, China, and the US will map cancer genes for liver, mouth, stomach and brain and pancreas.

The head of the British Cancer Research Institute, Harpal Kumar, said: 'There has never been any potential for gene therapy to benefit patients as in this study'.